Figure 2
Probability of OS. (A) OS in the entire patient population (N = 36) at a median follow-up of 32.6 months. *Two patients who were alive at the last follow-up at 29.7 and >29.9 months were censored at these visits and were considered to have an OS of ≥30 months after rounding to the nearest whole number. (B) Simon-Makuch analysis of OS in patients with and without MRD response. (C) OS with and without prior allo-SCT in the entire patient population (N = 36) at a median follow-up of 32.6 months. HSCT, hematopoietic stem cell transplantation.

Probability of OS. (A) OS in the entire patient population (N = 36) at a median follow-up of 32.6 months. *Two patients who were alive at the last follow-up at 29.7 and >29.9 months were censored at these visits and were considered to have an OS of ≥30 months after rounding to the nearest whole number. (B) Simon-Makuch analysis of OS in patients with and without MRD response. (C) OS with and without prior allo-SCT in the entire patient population (N = 36) at a median follow-up of 32.6 months. HSCT, hematopoietic stem cell transplantation.

Close Modal

or Create an Account

Close Modal
Close Modal